Hasegawa Y - Search Results

1

Pharmacogenetic association between GSTP1 genetic polymorphism and febrile neutropenia in Japanese patients with early breast cancer.

Sugishita M, Imai T, Kikumori T, Mitsuma A, Shimokata T, Shibata T, Morita S, Inada-Inoue M, Sawaki M, Hasegawa Y, Ando Y. Sugishita M, et al. Among authors: hasegawa y. Breast Cancer. 2016 Mar;23(2):195-201. doi: 10.1007/s12282-014-0547-x. Epub 2014 Jul 10. Breast Cancer. 2016. PMID: 25008867

2

Prognostic factors for short-term survival in patients with stage IV non-small cell lung cancer.

Ando M, Ando Y, Sugiura S, Minami H, Saka H, Sakai S, Shimokata K, Hasegawa Y. Ando M, et al. Among authors: hasegawa y. Jpn J Cancer Res. 1999 Feb;90(2):249-53. doi: 10.1111/j.1349-7006.1999.tb00740.x. Jpn J Cancer Res. 1999. PMID: 10189897 Free PMC article.

3

Pharmacological analysis of etoposide in elderly patients with lung cancer.

Ando M, Minami H, Ando Y, Sakai S, Shimono Y, Sugiura S, Saka H, Shimokata K, Hasegawa Y. Ando M, et al. Among authors: hasegawa y. Clin Cancer Res. 1999 Jul;5(7):1690-5. Clin Cancer Res. 1999. PMID: 10430070 Clinical Trial.

4

Prediction equation for glomerular filtration rate.

Ando Y, Hasegawa Y. Ando Y, et al. Among authors: hasegawa y. Ann Intern Med. 1999 Oct 19;131(8):629-30; author reply 630. doi: 10.7326/0003-4819-131-8-199910190-00018. Ann Intern Med. 1999. PMID: 10523230 No abstract available.

5

Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis.

Ando Y, Saka H, Ando M, Sawa T, Muro K, Ueoka H, Yokoyama A, Saitoh S, Shimokata K, Hasegawa Y. Ando Y, et al. Among authors: hasegawa y. Cancer Res. 2000 Dec 15;60(24):6921-6. Cancer Res. 2000. PMID: 11156391

6

Transforming growth factor-beta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma.

Hasegawa Y, Takanashi S, Kanehira Y, Tsushima T, Imai T, Okumura K. Hasegawa Y, et al. Cancer. 2001 Mar 1;91(5):964-71. Cancer. 2001. PMID: 11251948

7

Genetic polymorphisms of thiopurine S-methyltransferase and 6-mercaptopurine toxicity in Japanese children with acute lymphoblastic leukaemia.

Ando M, Ando Y, Hasegawa Y, Sekido Y, Shimokata K, Horibe K. Ando M, et al. Among authors: hasegawa y. Pharmacogenetics. 2001 Apr;11(3):269-73. doi: 10.1097/00008571-200104000-00011. Pharmacogenetics. 2001. PMID: 11337943 No abstract available.

8

Prognostic value of performance status assessed by patients themselves, nurses, and oncologists in advanced non-small cell lung cancer.

Ando M, Ando Y, Hasegawa Y, Shimokata K, Minami H, Wakai K, Ohno Y, Sakai S. Ando M, et al. Among authors: hasegawa y. Br J Cancer. 2001 Nov 30;85(11):1634-9. doi: 10.1054/bjoc.2001.2162. Br J Cancer. 2001. PMID: 11742480 Free PMC article.

9

Phase I/II and pharmacologic study of irinotecan and carboplatin for patients with lung cancer.

Sato M, Ando M, Minami H, Ando Y, Ando M, Yamamoto M, Sakai S, Watanabe A, Ikeda T, Sekido Y, Saka H, Shimokata K, Hasegawa Y. Sato M, et al. Among authors: hasegawa y. Cancer Chemother Pharmacol. 2001 Dec;48(6):481-7. doi: 10.1007/s002800100355. Cancer Chemother Pharmacol. 2001. PMID: 11800029 Clinical Trial.

10

Polymorphisms of UDP-glucuronosyltransferase and pharmacokinetics of irinotecan.

Ando Y, Ueoka H, Sugiyama T, Ichiki M, Shimokata K, Hasegawa Y. Ando Y, et al. Among authors: hasegawa y. Ther Drug Monit. 2002 Feb;24(1):111-6. doi: 10.1097/00007691-200202000-00018. Ther Drug Monit. 2002. PMID: 11805731

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,775 results

Search Page

Filters